Collectively, our data indicates that, in addition to controlling tumor-specific proliferation, the IL-17RC-A20 axis has a regulatory role in selectively repressing production of pro-inflammatory cytokines, including IL-6 and GM-CSF, but not CXCL1. This evidence concerns the gene TNFAIP3 and neoplasm.